SPECT Clinical Trials

521 recruitingLast updated: June 18, 2026

There are 521 actively recruiting spect clinical trials across 52 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Boston, Massachusetts, United States, Stanford, California, United States, Paris, France. Updated daily from ClinicalTrials.gov.


SPECT Trials at a Glance

521 actively recruiting trials for spect are listed on ClinicalTrialsFinder across 6 cities in 52 countries. The largest study group is Not Applicable with 269 trials, with the heaviest enrollment activity in Boston, Stanford, and Paris. Lead sponsors running spect studies include Stanford University, Riphah International University, and Istituto per la Ricerca e l'Innovazione Biomedica.

Treatments under study

About SPECT Clinical Trials

Looking for clinical trials for SPECT? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new SPECT trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about SPECT clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 521 trials

Recruiting
Phase 1Phase 2

Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study

AutismAutism Spectrum DisorderAutism Spectrum Disorder (ASD)+1 more
Adia Med of Winter Park LLC100 enrolled1 locationNCT07304440
Recruiting

Cohort Study on Neuroimmune Diseases in the Reproductive Age

Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+3 more
Third Affiliated Hospital, Sun Yat-Sen University100 enrolled1 locationNCT07653984
Recruiting
Not Applicable

Investigating Autimia, a Digital Intervention for Patients With Autism Spectrum Disorder

Autism Spectrum Disorder
Gaia AG236 enrolled1 locationNCT07638657
Recruiting
Phase 3

Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability Study, Will be Followed by a 10-week Open-label Study With Arbaclofen (4 Weeks of Titration and Then 6 Weeks of Active/Stable Treatment). The Effects of Arbaclofen on Target EEG and ERG Metrics Will be Associated With th

Autism Spectrum Disorders
Hospital General Universitario Gregorio Marañon103 enrolled5 locationsNCT07655115
Recruiting

Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)

MRIMultiple SclerosisNMO Spectrum Disorder+1 more
Beijing Tiantan Hospital1,000 enrolled1 locationNCT04106830
Recruiting

Spectroscopic Analysis of Tongue Tumor Samples.

Squamous Cell CarcinomaOral CavityMass Spectroscopy+3 more
Centre Hospitalier Universitaire, Amiens33 enrolled1 locationNCT05104619
Recruiting
Not Applicable

rTMS to Improve Motor Function in Autism

Autism Spectrum DisorderMotor Activity
Centre for Addiction and Mental Health150 enrolled1 locationNCT06497920
Recruiting
Not Applicable

How Simplified Language Affects Comprehension and Learning in Young Autistic Children

Autism Spectrum Disorder
Michigan State University104 enrolled1 locationNCT05707923
Recruiting
Phase 2

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

PIK3CA MutationVascular AnomaliesVascular Malformations+5 more
Relay Therapeutics, Inc.277 enrolled34 locationsNCT06789913
Recruiting
Not Applicable

Use of Immersive Virtual Reality to Train the Multisensory Processing Capacities of Children Aged 8 to 16 Years-old With an Autism Spectrum Disorder: Single-center Randomized Pilot Study in Parallel Groups - SEVIRE. (Sensory Virtual Reality)

Autism Spectrum Disorder
University Hospital, Tours50 enrolled2 locationsNCT05171244
Recruiting

Study of Proteus Syndrome and Related Congenital Disorders

Proteus SyndromePIK3CA Related Overgrowth Spectrum
National Human Genome Research Institute (NHGRI)1,500 enrolled1 locationNCT00001403
Recruiting
Phase 2

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

PIK3CA-Related Overgrowth Spectrum (PROS)
Novartis Pharmaceuticals104 enrolled32 locationsNCT06997588
Recruiting
Not Applicable

STABLE Pilates for Hypermobility

Ehlers-Danlos Syndrome (EDS)Hypermobile EDS (hEDS)Hypermobile Spectrum Disorder
Brigham and Women's Hospital100 enrolled1 locationNCT07464093
Recruiting
Not Applicable

Feasibility Study of UP-A-AST Parent Group for Adolescents With Autism and Co-occurring Anxiety/Depression

Depressive DisorderAnxiety DisordersAutistic Spectrum Disorder
Sahlgrenska University Hospital72 enrolled1 locationNCT07637799
Recruiting
Not Applicable

FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis

PsychosisSchizophrenia Spectrum Disorders (SSD)First-episode Psychosis+4 more
Stephanie Mehl252 enrolled8 locationsNCT07645443
Recruiting

Diagnostic Trial of a Vision Transformer-Based Ultrasound AI Model for Placenta Accreta Spectrum

Placenta Accreta Spectrum
FANG HE561 enrolled1 locationNCT07643090
Recruiting
Not Applicable

Early Diagnostic Response Model (EDRM)

AutismAutism Spectrum Disorder
Emory University300 enrolled1 locationNCT05419895
Recruiting
Not Applicable

Fecal Microbiota Transplantation in Children With ASD

Autism Spectrum Disorder
Shenzhen Children's Hospital1 enrolled1 locationNCT07381374
Recruiting
Phase 3

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

Neuromyelitis Optica Spectrum DisorderNMOSD
Hoffmann-La Roche8 enrolled13 locationsNCT05199688
Recruiting
Not Applicable

Retrieval-Based Word Learning in Autistic Children

Autism Spectrum Disorder
Louisiana State University and A&M College64 enrolled1 locationNCT06466876